Luken Investment Analytics’s CVS Health CVS Stock Holding History

Luken Investment Analytics’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$401K	Hold	3,881	–	–	0.14%	52
2026 Q1	$279K	Sell	3,881 -15	-0.4%	-$1.16K	0.11%	51
2025 Q4	$309K	Buy	3,896 +15	+0.4%	+$1.18K	0.12%	45
2025 Q3	$293K	Hold	3,881	–	–	0.11%	45
2025 Q2	$268K	Hold	3,881	–	–	0.12%	45
2025 Q1	$263K	Sell	3,881 -393	-9%	-$23.5K	0.12%	42
2024 Q4	$192K	Hold	4,274	–	–	0.09%	46
2024 Q3	$269K	Hold	4,274	–	–	0.12%	45
2024 Q2	$252K	Hold	4,274	–	–	0.13%	46
2024 Q1	$341K	Hold	4,274	–	–	0.17%	38
2023 Q4	$337K	Sell	4,274 -290	-6%	-$20.6K	0.18%	37
2023 Q3	$319K	Hold	4,564	–	–	0.18%	39
2023 Q2	$316K	Hold	4,564	–	–	0.18%	33
2023 Q1	$339K	Hold	4,564	–	–	0.2%	31
2022 Q4	$425K	Buy	+4,564	New	+$440K	0.27%	27
2020 Q4	$358K	Buy	+5,246	New	+$341K	0.27%	24

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Luken Investment Analytics's CVS Position: Q2 2026 in Review

Luken Investment Analytics held its CVS Health (CVS) position steady in Q2 2026 at 3,881 shares worth $401K. The position accounts for 0.14% of the portfolio, ranked #52.

Luken Investment Analytics first reported a position in CVS in Q4 2020 and has held it in 16 quarters since. The position peaked at $425K in Q4 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Luken Investment Analytics held 3,881 shares of CVS Health worth $401K as of Q2 2026.
Luken Investment Analytics left its CVS Health share count unchanged in Q2 2026.
CVS Health made up 0.14% of Luken Investment Analytics's portfolio in Q2 2026, its #52 holding.
Luken Investment Analytics first reported a position in CVS Health in Q4 2020 and has held it in 16 quarters since.
Luken Investment Analytics's CVS Health position peaked at $425K in Q4 2022.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Luken Investment Analytics's 13F filing for Q2 2026, filed 28 Jul 2026.